FDA Investigator: Yaharn Su
- Yaharn Su first started conducting FDA inspections in 2023, with the last inspection in 2024. Over that time, Yaharn Su has conducted 7 inspections at 7 companies across 7 sites.
Get Yaharn Su's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Granules Pharmaceuticals, Chantilly | December 2023
Available Now - $199
Yaharn Su
Human Drugs Form 483
FDA 483 Diamond Chemical Co. Inc., East Rutherford | 2024
Out-of-stock
Yaharn Su
Human Drugs Form 483
FDA 483 Sure-Biochem Laboratories, LLC, Camden | 2024
Out-of-stock
Yaharn Su
Human Drugs Form 483
FDA 483 WES Pharma Inc., Westminster | 2023
Out-of-stock
Yaharn Su
Human Drugs Form 483
FDA 483 DuPont Nutrition USA, Inc, Newark | 2023
Out-of-stock
Yaharn Su
Human Drugs Form 483
Co-Investigators (13)
- Victoria Spivak, FDA Investigator
- Jenny Sung, FDA Investigator
- Pushpa S. Jayasekara, FDA Investigator
- Catherine O. Lamptey,
- Azeezat M. Lawal,
- Christina K. Theodorou, FDA Investigator
- Yoriann M. Cabrera Bartolomei, FDA Investigator
- Tekalign Wondimu, FDA Investigator
- Johnny D. Nwankwo,
- Olumide A. Akinyemi,
- James R. Birkenstamm, FDA Investigator
- Suchan Kim, FDA Investigator
- Jonah S. Ufferfilge, FDA Investigator